Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
7/26/2024
Recent Official and Executive Moves
7/26/2024
CDE Solicits Public Comments on the Pharmaceutic Self-Assessment Repor...
7/26/2024
CStone Announces EC Approval of Sugemalimab (Cejemly®) as First-Line ...
7/25/2024
Innorna Receives IND Clearance for IN001 Herpes Zoster mRNA Vaccine in...
7/25/2024
Merck Group CEO Envisions AI-Driven Pharmaceutical Innovation Ecosyste...
7/25/2024
CDE Solicits Public Comments on the Technical Guidelines for Model-Gui...
7/25/2024
CDE Solicits Public Comments on the Technical Guidelines for Quality C...
7/25/2024
NMPA Accept Belief BioMed's NDA for China's First Gene Therapy for Hem...
7/25/2024
AI-Assisted Development of BGM0504: A Promising GLP-1R/GIPR Dual Agon...
7/24/2024
Pharmanovia to Continue Expansion and Investment in China
7/24/2024
BeiGene Opens New Clinical R&D and Biologics Manufacturing Facility in...
7/24/2024
Pfizer China President Praises China 's Reforms for Boosting Innovatio...
7/24/2024
CDE Solicits Public Comments on the Guidelines for Setting Limits on R...
7/24/2024
CDE Solicits Public Comments on the Technical Guideline for the Study ...
7/23/2024
CCP Pledges "Health-First Strategy" for Medical and Healthcare Reform
7/23/2024
Global Drugmakers Pursue Deals in China Despite Tensions
7/23/2024
NHSA Issues the DRG and DIP Grouping Plans V2.0
7/23/2024
Aligos Partners with Xiamen Amoytop Biotech for New CHB Treatment Stud...
7/23/2024
Triastek Announces Research License Deal with BioNTech to Advance 3D P...
7/23/2024
Fosun and Kite Pharma Agree to Convert Debt to Equity, Increasing JV F...
7/22/2024
Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
7/22/2024
Innovent's Lilly-Partnered Type 2 Diabetes Drug Succeeds in Phase III ...
7/22/2024
Wantai, GSK Terminate HPV Vaccine Development Deal
7/19/2024
Recent Executive Moves
7/19/2024
Chinese and Visiting Japanese Top Healthcare Officials Agree to Promot...
7/19/2024
Beijing to Build International Pharma Innovation Park
7/19/2024
CDE Solicits Public Comments on the Technical Guidelines for In Vitro ...
7/19/2024
NHSA: DRG Grouping V2.0 to Be Released, Policy Tilt Towards Innovative...
7/19/2024
Eli Lilly Wins Label Expansion for Tirzepatide in China
7/19/2024
Exscientia Acquires Full Control of CDK7 Drug, Plans Breast Cancer Com...
Page:
25
/
42
Total number of articles:
1234
:
[First]
[<<]
[23]
[24]
[25]
[26]
[27]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit